The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Merck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug regimen of ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

A bill filed in Springfield would allow doctors to prescribe some HIV medication without needing prior authorization.